Ligand Insider Sale: Martine’s $298.50 Transaction Amid Rising Revenue & 76% Stock Rally
Insightful insider sale by Ligand Pharma’s execs: 115 shares sold but company’s €23 M royalty deal with Santen and 76 % YTD rally keep confidence high—watch for future moves.
3 minutes to read